These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 25143376)
1. Short-chain fructo-oligosaccharide and inulin modulate inflammatory responses and microbial communities in Caco2-bbe cells and in a mouse model of intestinal injury. Johnson-Henry KC; Pinnell LJ; Waskow AM; Irrazabal T; Martin A; Hausner M; Sherman PM J Nutr; 2014 Nov; 144(11):1725-33. PubMed ID: 25143376 [TBL] [Abstract][Full Text] [Related]
5. Characterizing microbiota-independent effects of oligosaccharides on intestinal epithelial cells: insight into the role of structure and size : Structure-activity relationships of non-digestible oligosaccharides. Akbari P; Fink-Gremmels J; Willems RHAM; Difilippo E; Schols HA; Schoterman MHC; Garssen J; Braber S Eur J Nutr; 2017 Aug; 56(5):1919-1930. PubMed ID: 27295033 [TBL] [Abstract][Full Text] [Related]
6. Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Kim MH; Kang SG; Park JH; Yanagisawa M; Kim CH Gastroenterology; 2013 Aug; 145(2):396-406.e1-10. PubMed ID: 23665276 [TBL] [Abstract][Full Text] [Related]
8. Inulin and fructo-oligosaccharides have divergent effects on colitis and commensal microbiota in HLA-B27 transgenic rats. Koleva PT; Valcheva RS; Sun X; Gänzle MG; Dieleman LA Br J Nutr; 2012 Nov; 108(9):1633-43. PubMed ID: 22243836 [TBL] [Abstract][Full Text] [Related]
9. Infection and antibiotic-associated changes in the fecal microbiota of Mühlen S; Heroven AK; Elxnat B; Kahl S; Pieper DH; Dersch P Antimicrob Agents Chemother; 2024 May; 68(5):e0005724. PubMed ID: 38526080 [TBL] [Abstract][Full Text] [Related]
10. Human cathelicidin LL-37 exerts amelioration effects against EHEC O157:H7 infection regarding inflammation, enteric dysbacteriosis, and impairment of gut barrier function. Fang X; Nong K; Wang Z; Jin Y; Gao F; Zeng Q; Wang X; Zhang H Peptides; 2023 Jan; 159():170903. PubMed ID: 36370932 [TBL] [Abstract][Full Text] [Related]
11. Prophylactic and therapeutic supplementation using fructo-oligosaccharide improves the intestinal homeostasis after mucositis induced by 5- fluorouracil. Carvalho PLA; Andrade MER; Trindade LM; Leocádio PCL; Alvarez-Leite JI; Dos Reis DC; Cassali GD; Souza E Melo ÉLS; Dos Santos Martins F; Fernandes SOA; Gouveia Peluzio MDC; Generoso SV; Cardoso VN Biomed Pharmacother; 2021 Jan; 133():111012. PubMed ID: 33254017 [TBL] [Abstract][Full Text] [Related]
12. Galacto-oligosaccharides Protect the Intestinal Barrier by Maintaining the Tight Junction Network and Modulating the Inflammatory Responses after a Challenge with the Mycotoxin Deoxynivalenol in Human Caco-2 Cell Monolayers and B6C3F1 Mice. Akbari P; Braber S; Alizadeh A; Verheijden KA; Schoterman MH; Kraneveld AD; Garssen J; Fink-Gremmels J J Nutr; 2015 Jul; 145(7):1604-13. PubMed ID: 26019243 [TBL] [Abstract][Full Text] [Related]
13. Gut microbiome-mediated modulation of hepatic cytochrome P450 and P-glycoprotein: impact of butyrate and fructo-oligosaccharide-inulin. Walsh J; Gheorghe CE; Lyte JM; van de Wouw M; Boehme M; Dinan TG; Cryan JF; Griffin BT; Clarke G; Hyland NP J Pharm Pharmacol; 2020 Aug; 72(8):1072-1081. PubMed ID: 32337713 [TBL] [Abstract][Full Text] [Related]
14. Early administration of probiotic Lactobacillus acidophilus and/or prebiotic inulin attenuates pathogen-mediated intestinal inflammation and Smad 7 cell signaling. Foye OT; Huang IF; Chiou CC; Walker WA; Shi HN FEMS Immunol Med Microbiol; 2012 Aug; 65(3):467-80. PubMed ID: 22524476 [TBL] [Abstract][Full Text] [Related]
15. The Combination of 2'-Fucosyllactose with Short-Chain Galacto-Oligosaccharides and Long-Chain Fructo-Oligosaccharides that Enhance Influenza Vaccine Responses Is Associated with Mucosal Immune Regulation in Mice. Xiao L; Engen PA; Leusink-Muis T; van Ark I; Stahl B; Overbeek SA; Garssen J; Naqib A; Green SJ; Keshavarzian A; Folkerts G; Van't Land B J Nutr; 2019 May; 149(5):856-869. PubMed ID: 31050747 [TBL] [Abstract][Full Text] [Related]
16. Bacillus amyloliquefaciens TL106 protects mice against enterohaemorrhagic Escherichia coli O157:H7-induced intestinal disease through improving immune response, intestinal barrier function and gut microbiota. Bao CL; Liu SZ; Shang ZD; Liu YJ; Wang J; Zhang WX; Dong B; Cao YH J Appl Microbiol; 2021 Jul; 131(1):470-484. PubMed ID: 33289241 [TBL] [Abstract][Full Text] [Related]
17. Deprivation of dietary fiber in specific-pathogen-free mice promotes susceptibility to the intestinal mucosal pathogen Neumann M; Steimle A; Grant ET; Wolter M; Parrish A; Willieme S; Brenner D; Martens EC; Desai MS Gut Microbes; 2021; 13(1):1966263. PubMed ID: 34530674 [TBL] [Abstract][Full Text] [Related]
18. Dietary calcium phosphate strongly impacts gut microbiome changes elicited by inulin and galacto-oligosaccharides consumption. Fuhren J; Schwalbe M; Boekhorst J; Rösch C; Schols HA; Kleerebezem M Microbiome; 2021 Nov; 9(1):218. PubMed ID: 34732247 [TBL] [Abstract][Full Text] [Related]
19. Protein kinase C δ signaling is required for dietary prebiotic-induced strengthening of intestinal epithelial barrier function. Wu RY; Abdullah M; Määttänen P; Pilar AV; Scruten E; Johnson-Henry KC; Napper S; O'Brien C; Jones NL; Sherman PM Sci Rep; 2017 Jan; 7():40820. PubMed ID: 28098206 [TBL] [Abstract][Full Text] [Related]
20. Prebiotics Reduce Body Fat and Alter Intestinal Microbiota in Children Who Are Overweight or With Obesity. Nicolucci AC; Hume MP; Martínez I; Mayengbam S; Walter J; Reimer RA Gastroenterology; 2017 Sep; 153(3):711-722. PubMed ID: 28596023 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]